Patents by Inventor Marco VILLANI

Marco VILLANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230308835
    Abstract: A determination is made that a mobile device is associated with a reference activity of a user based on motion, orientation, rotational, magnetic field, and/or location data provided by sensors of the device. Activity data associated with the reference activity is obtained from the sensor-provided data. The activity data is recorded on the device for a configured period of time after which it is determined that the device is no longer performing the reference activity. The retained activity data for the reference activity is sent from the device to a network-based behavior analyzer when a network connection is available from the device. The network-based behavior analyzer derives user behaviors for the reference activity based on the activity data.
    Type: Application
    Filed: September 4, 2020
    Publication date: September 28, 2023
    Inventors: Sebastien IRIGARAY, Laurent KLEIN, Darko SKEGRO, Marco VILLANI, Karl WELZENBACH
  • Publication number: 20230265160
    Abstract: The present invention relates to fusion proteins suitable for use as a medicament or research tool. Therapeutic uses of the fusion proteins may include the prevention or treatment of acute or chronic inflammatory and immune system-driven organ and micro-vascular disorders, for example, acute kidney injury, acute myocardial infarction, acute respiratory distress or chronic obstructive pulmonary disease fibrosis and other organ injuries resulting from tissue trauma and acute and chronic injury.
    Type: Application
    Filed: September 4, 2020
    Publication date: August 24, 2023
    Inventors: Sebastien IRIGARAY, Laurent KLEIN, Darko SKEGRO, Marco VILLANI, Karl WELZENBACH
  • Publication number: 20230220048
    Abstract: The present invention relates to fusion proteins suitable for use as a medicament or research tool. Therapeutic uses of the fusion proteins may include the prevention or treatment of acute or chronic inflammatory and immune system-driven organ and micro-vascular disorders, for example, acute kidney injury, acute myocardial infarction, acute respiratory distress or chronic obstructive pulmonary disease fibrosis and other organ injuries resulting from tissue trauma and acute and chronic injury.
    Type: Application
    Filed: September 4, 2020
    Publication date: July 13, 2023
    Inventors: Sebastien IRIGARAY, Laurent KLEIN, Darko SKEGRO, Marco VILLANI, Karl WELZENBACH